<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0235266</journal-id>
<journal-id journal-id-type="pubmed-jr-id">7613</journal-id>
<journal-id journal-id-type="nlm-ta">Stroke</journal-id>
<journal-id journal-id-type="iso-abbrev">Stroke</journal-id>
<journal-title-group>
<journal-title>Stroke</journal-title>
</journal-title-group>
<issn pub-type="ppub">0039-2499</issn>
<issn pub-type="epub">1524-4628</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29866755</article-id>
<article-id pub-id-type="pmc">6019570</article-id>
<article-id pub-id-type="doi">10.1161/STROKEAHA.118.020627</article-id>
<article-id pub-id-type="manuscript">NIHMS965520</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Inhibition of miR-141-3p ameliorates the negative effects of post-stroke social isolation in aged mice</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Verma</surname>
<given-names>Rajkumar</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ritzel</surname>
<given-names>Rodney M.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Harris</surname>
<given-names>Nia M</given-names>
</name>
<degrees>BS</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>Juneyoung</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>TaeHee</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pandi</surname>
<given-names>Gopal</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vemuganti</surname>
<given-names>Raghu</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McCullough</surname>
<given-names>Louise D</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN1">5</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Department of Neuroscience, UConn Health, Farmington, CT 06032, USA</aff>
<aff id="A2">
<label>2</label>Department of Neurology, McGovern Medical School University of Texas Health Science Center, Houston, TX 77030, USA</aff>
<aff id="A3">
<label>3</label>Department of Neurological Surgery, University of Wisconsin, Madison, WI, 53706 USA</aff>
<aff id="A4">
<label>4</label>William S. Middleton Veterans Administration Hospital, Madison, WI, 53706 USA</aff>
<author-notes>
<corresp id="FN1"><label>5</label><bold>Corresponding author</bold>: Louise D McCullough, Department of Neurology, McGovern Medical School, University of Texas Health Science Center, 6431 Fannin Street – MSB 7.044, Houston, TX 77030, USA, <email>Louise.D.McCullough@uth.tmc.edu</email>, Phone: 713-500-7079, Fax- 713-500-0660</corresp>
<fn fn-type="COI-statement" id="FN2">
<p id="P30"><bold><italic>Conflict(s)-of-Interest/Disclosure(s)</italic>:</bold> None declared</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>20</day>
<month>5</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>04</day>
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>7</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>7</month>
<year>2019</year>
</pub-date>
<volume>49</volume>
<issue>7</issue>
<fpage>1701</fpage>
<lpage>1707</lpage>
<!--elocation-id from pubmed: 10.1161/STROKEAHA.118.020627-->
<abstract>
<sec id="S1">
<title>Background and Purpose</title>
<p id="P1">Social isolation increases mortality and impairs recovery after stroke in clinical populations. These detrimental effects have been recapitulated in animal models, although the exact mechanism mediating these effects remains unclear. Dysregulation of microRNAs (miRNAs) occurs in both stroke as well as after social isolation, which trigger changes in many downstream genes. We hypothesized that miRNA regulation is involved in the detrimental effects of post-stroke social isolation in aged animals.</p>
</sec>
<sec id="S2">
<title>Methods</title>
<p id="P2">We pair-housed 18-months-old male C57BL/6 male mice for two weeks prior to a 60-minute right middle cerebral artery occlusion or sham surgery and then randomly assigned mice to isolation or continued pair-housing immediately after surgery. We sacrificed mice either at 3, 7, or 15 days after surgery and isolated the perilesional frontal cortex for whole microRNAome (miRNAome) analysis. In an additional cohort, we treated mice one day after stroke onset with an ‘<italic>in vivo</italic>-ready’ inhibitor of miR-141-3p (antagomiR-141-3p) for three days.</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P3">Using whole miRNAome analysis of 752 miRNAs, we identified miR-141-3p as a unique miRNA that was significantly upregulated in isolated mice in a time-dependent manner up to two weeks after stroke. Post-treatment with an antagomiR-141-3p reduced the post-isolation-induced increase in miR-141-3p to levels almost equal to those of pair-housed stroke controls. This treatment significantly reduced mortality (by 21%) and normalized infarct volume and neurological scores in post-stroke isolated mice. Quantitative PCR analysis revealed a significant up regulation of <italic>neuroprotective</italic> genes including transforming growth factor beta receptor 1 (<italic>Tgfβr1</italic>, a direct target of miR-141-3p) and insulin-like growth factor 1 (<italic>Igf-1</italic>) after treatment with antagomiR. Treatment also increased the expression of other pleiotropic cytokines such as interleukin 6 <italic>(Il-6)</italic> and tumor necrosis factor alpha (<italic>Tnf-α</italic>, an indirect or secondary target) in brain tissue.</p>
</sec>
<sec id="S4">
<title>Conclusions</title>
<p id="P4">miR-141-3p is increased with post-stroke isolation. Inhibition of miR-141-3p improved mortality, neurological deficits, and decreased infarct volumes. Importantly, these therapeutic effects occurred in aged animals, the population most at risk for stroke and post-stroke isolation.</p>
</sec>
</abstract>
<kwd-group>
<kwd>microRNA</kwd>
<kwd>stroke</kwd>
<kwd>
<italic>neuroprotection</italic>
</kwd>
<kwd>social isolation</kwd>
<kwd>miR-141-3p</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>